CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p/CYP1B1 axis
2024 · Molecular Cancer · 53 citations
https://doi.org/10.1186/s12943-023-01912-w
M
Meng-Xin Leng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
37
Papers
149
Citations
5
h-index
5
i10-index
Meng-Xin Leng is an academic researcher. The author has contributed to research in topics: PARP inhibition in cancer therapy & Cancer Immunotherapy and Biomarkers & DNA Repair Mechanisms. The author has an h-index of 5, co-authored 32 publications.
ORCID: 0000-0002-0453-7337Papers by this author
worksO-GlcNAcylation regulation of RIPK1-dependent apoptosis dictates sensitivity to sunitinib in renal cell carcinoma
2024 · Drug Resistance Updates · 21 citations
https://doi.org/10.1016/j.drup.2024.101150
Organ-specific metastatic landscape dissects PD-(L)1 blockade efficacy in advanced non-small cell lung cancer: applicability from clinical trials to real-world practice
2022 · BMC Medicine · 18 citations
https://doi.org/10.1186/s12916-022-02315-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat